Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes they will open tomorrow at 1.2 p as thing got stings as it normal on AIM shares. No way any kind investment in AIM will bring profits inly for gamble as in and out quickly with pump and dump RNS .
I'm afraid the Ramping Police ruined this chatboard. Any doubt or deviation from an entirely positive view of this company was not tolerated and nastily put down. Usually when investors take such a blinkered, defensive mindset it doesn't end well. Even today, 5 minutes before the 73% discounted placing RNS lands, one of them is posting a happy smiley picture of Christopher von Jako at some trade fair. Talk about fiddling while Rome burns!
Partners buying.
Bastiaan has 10m shares being diluted any holders are going to be able to get some in the rock bottom placing.
- this confirms survival and the markets wanted that news it confirms going concern with proper sales traction.
Thoughts? Be nice to start of tomorrow with another sale too.
Again.. nobody cares what u have to say.. move along..
right. horrible price... positives...
holders can get 9 our of 10 held at 1p.
great if got dry powder.
- confirmed orders and a revenue for 2024 above targets upto £3m on current deals and current targets.
- large director participation (they're not ****in daft!)
- partn
Lol
Ya sure, 73% discounted placing and nobody cares! I remember those abusive posts and name calling, perhaps you should apologies now.
Looking at the bigger picture, this is great, but at least now the market will start to price in all the deals, and everything that will happen this year.. ppl will make easy 200/300% from the raise.., 50m mc will be 5p.. dilution is ridiculous and the bod need to give answers..
Nasty placing..
Feel sorry for holders who hold from teens..
It will bounce back, but they should’ve done a partnership deal.. II will gain the most from this
Neon, no one cares, move along…
Their share has pretty much 4 bagged back to near original price before the deliberate crash, in only 6 weeks.
and they'll be raising £8million... it's not 'housekeeping' money!
Told you all
I'm more intrigued that somehow a nomad has let an RNS out saying the directors are subscribing for upto $321 Billion. Good proof reading
Daylight robbery.. very poor from the co
Fingers crossed, was hoping this would be over 5 by now buy seems like it's stalled a bit. Hopefully a sharp rise soon.
Avalyn pharma are high on my list of potential customers, especially if the nebuliser trial went well that was announced in the rns 7th December
Impressive
Class Slick, fingers crossed
Richard Hulihen used to say the FDA approval for gas exchange would be supported by the previous research, rather than doing another clinical trial, cvj hasn’t ever said anything like that, but I still think it’s very possible.
That would be a great boost for the share price if we could save that time and expense, and sales would increase immediately
Impressive!
RATIONALE 129Xe magnetic resonance imaging (MRI) is sensitive to abnormalities in lung ventilation, microstructure and gas transfer, and may help to phenotype patients with clinical features of both asthma and chronic obstructive pulmonary disease(COPD).
- In patients with normal TLco and normal Kco, MRI gas exchange (red blood cell/gas) was significantly reduced in asthma+COPD (n=35) compared with asthma (n=67) and in COPD (n=10) compared with asthma.
CONCLUSIONS129Xe MRI metrics were significantly different between patients diagnosed with asthma, asthma+COPD and COPD. Patients with asthma had lower ventilation heterogeneity, smaller acinar dimensions and greater gas exchange compared with patients with asthma+COPD and COPD
- 129Xe MRI metrics distinguished between diagnostic sub-groups of patients with normal pulmonary function tests .
I really hope the FDA take studies like this into consideration when approving Gas Exchange rather than running further Clinical Trials.
Only a matter of time!